Meet the Faculty

Dr Mick Button

Consultant Clinical Oncologist Velindre Cancer Centre

MA MBBS MRCP, FRCR

Mick Button is a Consultant Clinical Oncologist and Associate Medical Director at Velindre Cancer Centre specialising in lung cancer. He completed a PCME alongside his oncology training, leads the Cardiff FRCR Course and has previously been the Training Programme Director and Specialty Training Committee Chair for Wales. Nationally, he sits on the RCR Specialty Training Board and is one the joint RCR Quality Assurance Leads for Clinical Oncology Training in the UK.

He is currently undertaking a Bevan Fellowship, building collaborative change networks in cancer teams in SE Wales and is leading the development of the proposed ‘Collaborative Centre for Learning and Innovation’ – an exciting part of the new Velindre Cancer Centre development to support future involvement, research, education and innovation.

When not at work, he enjoys spending time with his family and is often found on the waters around Wales on his paddle board.

Dr Ricky Fraser

Consultant Medical Oncologist, Velindre Cancer Centre

MBBCH (Hons), MSc (MedEduc), BSc, PGCert (Onc), PGCert (ClinLead), MAcadMEd, MRCP, AFFMLM   

Ricky Frazer is a Consultant Medical Oncologist working at Velindre Cancer Centre. He specialises in melanoma, renal cancer and acute oncology and is clinical lead for the acute oncology assessment unit at VCC and the immunotherapy toxicity management service. He has been heavily involved in the inception and development of the national Practical Management of your Immuno-Oncology Patient (PMI-OP) educational series exploring immunotherapy identification and management with specialist colleagues. He has been involved in writing the UKONS acute oncology management guidelines. Ricky was a Welsh Clinical Leadership Training Fellow with the Wales Deanery and is a Founding Associate Fellow of the Faculty of Medical Leadership and Management. He has a strong educational interest and is currently a Royal College of Physicians (RCP) College Tutor and a council member for the Academy of Medical Educators. He is also an Honorary Lecturer at Cardiff University. He has completed a Masters in medical education and was awarded the national Munro Medal by the RCP for excellence and leadership in education.

Ricky cofounded the popular Immunobuddies podcast.

Steve Hill

Planning & Palliative Pre-Treatment Radiographer, Velindre Cancer Centre

BSc Radiotherapy and Oncology, PgD Palliative Advanced Practice, Bevan Commission Exemplar

Steve has been a member of the Cardiff FRCR course faculty since 2014. He has over 16 years’ experience specialising as a pre-treatment radiographer, including 13 years working as a Palliative Advanced Practitioner. He is completing his MSc in palliative advanced practice. In addition to his involvement in the Cardiff FRCR course, he also teaches palliative planning to undergraduate radiotherapy students from Cardiff University. Steve is developing a rapid-access palliative radiotherapy clinic in VCC. together with the Bevan Commissions exemplar, Adopt and Spread, and Planned Care Innovation Pathway scheme. He has been a VCC lead for the national SCORAD trial.

 Dr Martin Rolles

Consultant Clinical Oncologist, South West Wales Cancer Centre

BSc (Hons) MBBCh MRCP FRCR

Martin Rolles is a Clinical Oncologist specialising in Head & Neck Cancer, and Non-Melanoma Skin Cancer. He is chair of the Wales Cancer Network Clinical Reference Group. He also chairs the Welsh Scientific Advisory Committee, and the All-Wales PBT, PET, and Molecular Radiotherapy Advisory Groups.

Martin sits on the Clinical Oncology Faculty Board, and the Council of the Royal College of Radiologists.

After taking a degree in Zoology at the University of Bristol, Martin read medicine at the University of Wales, returning after specialist training in Wessex and Vancouver.

Dr Craig Barrington

Consultant Clinical Oncologist, South West Wales Cancer Centre

FRCR, MRCP, MBBS, Bsc

Craig is a Consultant Clinical Oncologist specialising in Lower GI cancers and AOS. He is the lead for M&M and Audit in the South West Wales Cancer Centre. He sits on the National Steering Group for the RCR National Radiotherapy consent forms. He graduated from Newcastle University Medical School in 2011 after completing a BSc in Biomedical Science at Durham University. He has been a Cardiff FRCR course faculty member since 2020.

Dr Russell Banner

Consultant Clinical Oncologist, South West Wales Cancer Centre

MA MBBS MRCP MSc FRCR

Dr Russell Banner is a Consultant Clinical Oncologist and the Clinical Director of the South West Wales Cancer Centre. His undergraduate training was at Christ’s College, Cambridge and then at Guy’s, Kings and St. Thomas’ Medical School in London, qualifying in 2002. He trained as a junior doctor in London and became convinced of a career in Clinical Oncology after working for 6 months in the Royal Marsden Hospital.

He started his speciality training in Canterbury in 2007 and then transferred to South Wales, gaining Fellowship of the Royal College of Radiologists in 2010. He undertook an Advanced Radiotherapy Clinical Research Fellowship at Velindre Cancer Centre in 2011 and completed his MSc with the Institute of Cancer Research in London in 2013 researching Human Papilloma Virus specific T-cell immune responses before and after chemoradiotherapy for oropharyngeal cancer.

Russell took up his post as a Consultant Clinical Oncologist in the South West Wales Cancer Centre in 2013.  He is enthusiastically research active with Principal Investigator roles in Swansea for a number of UK-wide randomised clinical research radiotherapy trials as well as being on the Trial Management Group for the Head and Neck Proton RCT, Torpedo. He has developed an interest in Radiotherapy Quality Improvement and Performance in his role as Radiotherapy Lead in the South West Wales Cancer Centre. He has been a member of the Cardiff FRCR course faculty for over a decade now.

Russell specialises in treating head & neck cancers and non-melanoma skin cancers. He particularly enjoys his clinical week treating patients with a spectrum of radiotherapy techniques from clinical mark ups, through adaptive VMAT to proton beam therapy.

Dr Thomas Rackley

Consultant Clinical Oncologist, Velindre Cancer Centre

MBBCH MRCP FRCR

Dr Thomas Rackley is a Consultant Clinical Oncologist at Velindre Cancer Centre, specialising in head and neck and anal cancer. He has implemented the use of stereotactic ablative body radiotherapy (SABR) for oligometastatic disease and liver HCC.

His medical degree was obtained at Cardiff University and medical training was throughout Wales. Oncology training was in south Wales and included an advanced radiotherapy fellowship in head and neck cancer. A further fellowship was achieved in the BC Cancer Agency Vancouver where he learnt his skills in SABR delivery and SABR clinical trial set up. He is a member of the SABR consortium steering committee and regularly delivers contouring training as part of the UK SABR expansion program. He has a keen interest in research and achieved a Health and Care Research Wales funding award and is currently co-CI on a multicentre trial on adaptive radiotherapy in oropharyngeal cancer. He also collaborates with Cardiff University on a study investigating immune responses in SABR. Since being appointed a consultant in VCC in 2016 he has been a FRCR course faculty member. 

Dr Najmus Sahar Iqbal

Consultant Clinical Oncologist, Velindre Cancer Centre

MB BCh, MRCP (UK), FRCR, PhD

Dr Sahar Iqbal is a consultant clinical oncologist at Velindre Cancer Centre specialising in CNS and thoracic malignancy . Her research interest is functional imaging in cancer, particularly application of advanced imaging in assessment of response to treatment, effect of radiation on normal tissue and prognostic and predictive non-invasive biomarkers in cancer. Her PhD looked at neurocognitive impairment following stereotactic radiosurgery for brain metastases. Her research involves functional MRI imaging of patient pre and post treatment using 3T and Connectome MRI scanner at Cardiff University Brain Research Imaging Centre.

Dr Louise Hanna

Consultant Clinical Oncologist, Velindre Cancer Centre

MA BMBCh MRCP FRCR

Dr Louise Hanna graduated from Cambridge and Oxford Universities before undertaking a medical rotation based in Addenbrooke’s Hospital in Cambridge.  She trained in clinical oncology in the Velindre Cancer Centre in Cardiff and became a consultant in 2001, specialising in gynaecological and lung cancer and joining the FRCR course faculty. 

Louise has a keen interest in medical education. She is the RCR Medical Director, Education and Training, Clinical Oncology. She is the lead editor of the textbook Practical Clinical Oncology (Cambridge University Press) which is now in its second edition. Louise is also an Associate Dean in the training quality unit in the newly established special Health Authority, Health Education and Improvement Wales. 

Additionally, Louise is chair of the Wales Cancer Network Gynaecological Cancer Site Group and a member of the International Cancer Benchmarking Partnership Clinical Committee, the British Gynaecological Cancer Society and CTRad. 

Dr Elin Evans

Consultant Clinical Oncologist, Velindre Cancer Centre

MBBS MRCP FRCR MD

Elin is a Consultant Clinical Oncologist at Velindre Cancer Centre, specialising in Urological and Head & Neck Malignancies. She graduated from Guys, King’s and St Thomas’ School of Medicine London in 2006 and completed foundation training in the UK before working as a junior doctor in Australia for two years. Elin undertook oncology training in South Wales and has a particular interest in Medical Education, completing a postgraduate certificate in medical education at Dundee University. She completed an MD at Cardiff University in advanced prostate radiotherapy.

Dr Carys Morgan

Consultant Clinical Oncologist, Velindre Cancer Centre

MBChB MRCP FRCR

Dr Carys Morgan is a clinical oncologist in Velindre Cancer centre specialising in the treatment of oesophagogastric cancer, neuroendocrine tumours and gastrointestinal stromal tumours with an particular interest in delivery of oesophageal chemoradiotherapy. Alongside her clinical work, she is upper GI cancer lead for the Wales Cancer Network currently focusing on UGI pathway improvement and equity of access to high quality research for patients in Wales.

Lucy Wills

Principal Treatment Planning Healthcare Scientist Velindre Cancer Centre

BSc (Hons), RCT, IIPEM, RSci

Lucy Wills is a Clinical Technologist in the Radiotherapy Treatment Planning Section at Velindre Cancer Centre, Cardiff. She graduated in Physics with Astronomy from the University Of Wales and started her career in Radiotherapy Physics at Velindre in 2000.

As a treatment planning specialist she has seen the huge developments in treatment planning of the last two decades. She has been active in national training of clinical technologists and of other disciplines and has participated in radiotherapy clinical trials quality assurance projects. More recently she has been helping to develop Advanced Clinical Practice in Non-Medical Outlining of radiotherapy targets.

She has been a Velindre FRCR course faculty member since 2008.

Dr Betsan Thomas

Consultant Clinical Oncologist, Velindre Cancer Centre

BM, MRCP, FRCR

Dr Betsan Thomas is a consultant Clinical Oncologist at Velindre Cancer Centre. She is a member of the National Oesophago-Gastric Cancer Audit (NOGCA) group, evaluating the quality and care for patients with Oesophago-Gastric cancer in Wales and England.

She is a member of the ARENA (Assurances in Radiotherapy through Education and Assessment) project, aiming to standardise high-quality tumour volume delineation (TVD) training for UK clinical oncology trainees. 

Dr Jacob Tanguay

Consultant Clinical Oncologist, Velindre Cancer Centre

MBBS MRCP FRCR PhD

Dr Jake Tanguay took his medical degree in Birmingham and completed his training in Clinical Oncology in the West Midlands. He was awarded the Frank Doyle Medal by the Royal College of Radiologists as the highest scoring candidate nationally in the Fellowship of the Royal College of Radiologists part 1 exam.

He has been a consultant Clinical Oncologist at Velindre Cancer Centre since 2009 with a specialist interest in urological cancers. He has expertise in advanced radiotherapy techniques (including SABR, IMRT, brachytherapy), hormonal treatments, targeted therapies, immunotherapy and chemotherapy.
He has been the urological team lead at Velindre Cancer Centre since 2015. He is also a member of the Welsh National Urology Clinical Steering Group.

He is the Associate Medical Director of Clinical Informatics at Velindre and also national clinical lead for cancer informatics and the founder of the Oncopaedia website for FRCR part 2 training.

He has been an investigator for a number of major national and international trials including immunotherapy in bladder cancer and prostate cancer, SABR radiotherapy for prostate cancer, DNA target agents in prostate cancer, and the internationally renowned STAMPEDE trial.

He is the Welsh national lead for prostate brachytherapy and recently led on the introduction of high dose rate brachytherapy to Wales.

He grew up in Pembrokeshire and currently lives in the Vale of Glamorgan with his family. When not working he is a keen cyclist and hill walker.

Dr Niladri Ghosal

Consultant Clinical Oncologist, Clatterbridge Cancer Centre.

MRCP, FRCR, MSc

Dr Ghosal is a Consultant Clinical Oncologist in the Clatterbridge Cancer Centre, Liverpool. His main interests are in Lung, Breast and CNS malignancies.

He was awarded the Generation Q fellowship by the Health Foundation and successfully completed his Masters degree  in Quality Improvement and Leadership from the Ashridge Business School. Dr Ghosal has served as a part 1 FRCR examiner for many years and currently serves the RCR as the Co-Chair of the FRCR part 1 Exam Board.

Dr Sonali Dasgupta

Consultant Medical Oncologist, Velindre Cancer Centre

PhD, FRCR, PG Dip (Oncology)

Dr Sonali Dasgupta specialises in Colorectal Cancer and Carcinoma of Unknown Primary (CUP.)

Dr Gupta’s medical degree was from Kolkata, India. In 2016, she was awarded a PhD (Cancer Research UK) for identifying novel predictive/prognostic biomarkers in colorectal cancer (Queen’s University, Belfast, UK). In parallel, she was also awarded distinction marks in Post-Graduate Diploma for Oncology (Newcastle Uni, UK).

In Northern Ireland, Sonali led a brand new Acute Oncology service with a parallel running CUP service. Relocating back to Wales in 2019, she was the founder and Clinical Lead for CUP Service in South East Wales. In 2023, she was appointed as National (Wales Cancer Network) Lead for the CUP Cancer Site Group.

Dr Jilly Maclean

Consultant Clinical Oncologist, Velindre Cancer Centre

MBChB, MD(Res), FRCR, MRCP

Jilly Maclean is a Consultant Clinical Oncologist specialising in Neuro-oncology, Skull Base tumours (adult and paediatric) and Thyroid Cancer. She joined Velindre in 2019 having previously been a Consultant in Bristol.

Jilly completed her oncology training in London, followed by an MD(Res) in Advanced Radiotherapy for Meningiomas at UCL and a fellowship in radiosurgery at the University of Ottawa, Canada.  She has a particular interest in technical radiotherapy and radiosurgery for brain tumours. She is a member of the NCRI Brain Group and Meningioma/ Metastases subgroup and EORTC Brain Tumor Group driving clinical trial development in brain tumours and is a Principle Investigator/ Trial Steering Group member for several studies.

Professor Richard Adams

Consultant Clinical Oncologist, Velindre Cancer Centre

B.Med.Sci, BM BS, MRCP, FRCR, MD

Richard Adams is Professor of Cancer Clinical Trials, Director of the CRUK core funded Centre for Trials Research (Cancer Division), Clinical Director of the Wales Cancer Biobank and Honorary Consultant Clinical Oncologist at Cardiff University and Velindre Cancer Centre. His clinical practice and research is focused on lower gastrointestinal cancers. He is chair of the National Cancer Research Institute (NCRI) Colorectal group and the radiotherapy and early phase national CTRad research group , Chair of the CRUK Clinical Expert Review Panel and is active in national and international research organisations including IRCI the International Rare Cancer Initiative (for anal cancer), ESMO and ARCAD.

Richard is a Chief investigator on lower gastrointestinal cancer trials and leads on radiotherapy quality assurance programmes for UK anal and rectal cancer radiotherapy trials. He oversees collaborative translational research in numerous phase II/ III colorectal cancer trials. He was a founder member of and now chairs the South Wales Cancer Care link with Sierra Leone.

Dr. Prashanth Kainthaje Bhat

Specialty Doctor Oncology, South West Wales Cancer Centre

MBBS, FRCR, M.D (Radiotherapy, India)

Prashanth Bhat is a clinical oncologist specialising in CNS tumours, Lymphoma and Sarcoma. He graduated from Mysore Medical College, India and trained in Radiotherapy at Jodhpur. He worked at St. John’s Medical College, Bengaluru, India before moving to Swansea, Wales in October 2020. He is part of Wales Committee for ‘Breast cancer screening for women treated with radiotherapy’. He was a candidate at First Cardiff – TMC FRCR 2B course in India in May 2019.

Dr Caitlin Bowden

Consultant Clinical Oncologist, Cheltenham General Hospital

BMedsci, BMBS, MRCP, FRCR

Dr Caitlin Bowden is a Consultant Clinical Oncologist in Cheltenham General Hospital, Gloucestershire specialising in lung and urological cancers (prostate, bladder and renal). She has an interest in stereotactic ablative body radiotherapy (SABR) for early-stage lung cancer and for oligometastatic disease. Her medical training was at The University of Nottingham and Specialist Oncology training in South Wales. Dr Bowden has a keen interest in medical education, stemming from her senior registrar training where she was Chair of the Oncology Registrars Forum and is now Educational lead for Specialist Registrars within Gloucestershire.

Dr Sarah Gwynne

Consultant Clinical Oncologist, South West Wales Cancer Centre

Dr Sarah Gwynne specialises in OG and MUO. She is an honorary associate professor at Swansea University.

Sarah is a member of the South Wales NET MDT, which has recently been recommended for ENETS Centre of Excellence status.

Training the next generation of oncologists and researchers, has been a passion throughout her consultant career. She has been a clinical and educational supervisor and past RCR College Tutor in Swansea. She was shortlisted for RCR trainer of the year in 2020. From 2012 to 2014 she was a member of the question writing panel for the FRCR part 1 exam.

She sits on the RCR academic committee and is currently academic rep for the Wales Oncology Specialist Training Committee.

She has been involved in running national trials in radiotherapy with a RT QA focus, particularly around outlining and has published extensively in this area, in addition to being a member of the National RTTQA management group. She is clinical lead for the ARENA project which has developed a set of materials to support oncology trainees in outlining which will be shortly available to all UK trainees via the RCR.

Professor James Powell

Consultant Clinical Oncologist, Velindre Cancer Centre

MBBS, MRCP, FRCR, PhD 

Professor James Powell specialises in Neuro-Oncology and Lung cancer. He completed a PhD at Cardiff University, Division of Cancer Genetics in 2014. His research interest is in Neuro-Oncology and he collaborates with the Cardiff University Brain Research Imaging Centre developing novel imaging methods for adults with brain tumours. He is interested in evaluating the role of proton beam radiotherapy for adults with brain tumours and is co-applicant on the NCRI funded APPROACH clinical trial comparing neuro-cognitive outcomes between photon and proton radiotherapy in glioma. 

James is the clinical and research lead for Neuro-Oncology at Velindre Cancer Centre and he leads the Brain Multi-disciplinary Research Group in Cardiff. He is a member of the Glioma Subgroup of the NCRI Brain Clinical Studies Group. I have developed clinical trial activity in Cardiff, improving access to clinical trials for patients with brain tumours in Wales and am the lead local investigator for several brain tumour trials and sit on the trial management group of national trials in Neuro-Oncology. 

Dr Annabel Borley

Consultant Clinical Oncologist, Velindre Cancer Centre

MBChB  (Edin) MRCP FRCR MD 

Dr Annabel Borley is a Consultant Clinical Oncologist and Clinical Lead for the Breast Cancer Team at Velindre Cancer Centre in Cardiff. She graduated from Edinburgh University in 1995 and then completed higher medical and oncology training in Wales, gaining FRCR in 2003, followed by an MD from Cardiff University evaluating antioestrogen induced invasion in breast cancer cell lines in 2011.   

Annabel has a keen interest in late phase trials and is an experienced Principle Investigator. Alongside her clinical work Annabel is a member of the Wales Cancer Network Breast CSG, and has training roles for junior doctors and non medical prescribers. 

Dr Loretta Sweeney

Consultant Clinical Oncologist. Velindre Cancer Centre

Dr Loretta Sweeney specialising in urological cancer. She trained in Cardiff and undertook clinical oncology specialist training in South Wales.

I set up the local Radium 223 service for metastatic prostate cancer and has a special interest in Molecular Radiotherapy with a view to expanding access to specialist treatments for both local patients and those traveling from further afield.

Dr Anshu Wadhawan

Consultant Clinical Oncologist.

MBBS, MRCP, FRCR 

Anshu Wadhawan is a Locum Consultant Clinical Oncologist and  at Velindre Cancer Centre, Cardiff, specialising in Breast and Colorectal Cancer.   

Dr Owen Nicholas

Consultant Clinical Oncologist and Honorary Senior Lecturer

South West Wales Cancer Centre, and Faculty of Medicine, Health and Life Science, Swansea University.

MBBS, MRCP, FRCR, MD

Owen is a clinical oncologist specialising in Upper GI/HPB and breast cancer. His clinical and research interests lie in advanced radiotherapy techniques including proton beam therapy and SABR. He is an honorary senior lecturer in Swansea University where he is involved in the Radiation Physics MSc, and Graduate Entry Medicine programmes.  

Dr.Laura Jones

Specialist Grade Medical Oncologist, South West Wales Cancer Centre

MBBCh, MRCP, MRCGP

Dr Laura Jones graduated in 2001 from the University of Wales College of Medicine. She began Oncology Specialty training in Sheffield, before transferring to South Wales in 2008. She subsequently qualified as a GP before returning to oncology in 2019.  Her specialist tumour sites are Malignancy unknown origin/ Carcinoma unknown primary, Upper gastrointestinal and hepatobiliary. Her GP experience has led to an interest in lifestyle medicine, holistic care and cancer survivorship issues.

She is MUO/CUP MDT lead for Hywel Dda and Swansea Bay Health boards and Deputy Lead for Wales Cancer Network MUO/CUP cancer site group. She is the professional advisor for Maggie’s Centre in Swansea.

Dr. Sean Brown

Consultant Clinical Oncologist, Gloucestershire Oncology Centre,

Dr Brown specialises in lung and upper gastro-intestinal cancers. He has a specialist interest in stereotactic radiotherapy (SABR) for early lung cancer and oligometastates from other tumour sites.

Before taking up his Consultant post in Gloucestershire, Dr Brown completed his medical training in Liverpool and specialist oncology training at Clatterbridge Cancer Centre. In 2019 he was awarded an MD after undertaking a period of research at The Christie investigating the role of high precision radiotherapy in lung cancer.

Professor Mark Davies

Honorary Consultant in Clinical Genetics and Medical Oncology, All Wales Medical Genomics Service and Velindre Cancer Centre

Mark’s clinical work is focused on breast cancer and on children with inherited tumour predisposition syndromes. He has a long standing interesting in integrating genomics into oncology and is Deputy Chair of the All Wales Genomics Oncology Group.

Dr Jonathan Helbrow

Consultant Clinical Oncologist, Gloucestershire Oncology Centre and NIHR RTTQA group

MRes MRCP FRCR

Dr Jon Helbrow graduated from Manchester Medical School in 2012 following an intercalated MRes in Oncology at The Christie. His postgraduate training was undertaken between the Northwest and Severn deaneries, and gained further oncology expertise at Guy’s and St Thomas’ hospitals in London.

He undertook a radiotherapy research fellowship at the South West Wales Cancer Centre in Swansea, focusing on radiotherapy quality assurance in oesophgao-gastric clinical trials, and was the NIHR RTTQA clinical fellow during this time. He obtained a consultant post in upper GI malignancies and SABR in 2025 at Gloucestershire Oncology Centre, and continues as part of the NIHR RTTQA group.

His academic interests are in oesophago-gastric radiotherapy, quality assurance and cardio-oncology, in addition to AI auto-contouring, and he is a member of the PROTIEUS and ARCHERY trial management groups. He has a passion for education, and has been a member of the RCR working group driving the recent FRCR 2b changes, advocating for trainees and helping to provide educational material.

Dr Rachel Jones

Consultant Medical Oncologist

MB ChB, MD

Dr Rachel Jones is a Consultant Medical Oncologist specialising in ovarian cancer and testicular cancer.  Having trained at Bristol University she started her oncology training initially in Bristol and then as part of the South Wales training programme.  She completed her MD in prostate cancer at the University of Swansea and then worked as a consultant both at Velindre Cancer Centre and now at the South West Wales Cancer Centre in Swansea (SWWCC).  She has an active interest in research and has been a PI on many clinical trials and ensures active engagement with trials across UK for patients in South West Wales.  She is SACT lead for SWWCC and works closely with colleagues across Wales through All Wales SACT board and has been involved in the development and implementation of the new SACT Quality performance metrics.

Dr Jones has always had a strong interest in education and was Trainee Programme Director for Medical Oncology in Wales and then Chair of Combined Training Programme for over 10 years helping to support an increase in new training numbers and implementation of new curriculum across Wales.

Dr Ceri Powell

Consultant Clinical Oncologist, Velindre Cancer Centre

Ceri specialises in thoracic malignancies. She has a special interest in technical radiotherapy particularly SABR, and led the development of a SABR service at the South West Wales Cancer centre which was established in 2022. She has close links with the Royal College of Radiologists, having chaired the lung cancer consensus statements and co-chaired the lung cancer sessions and contouring workshops at the RCR22 annual conference. Ceri is a member of the UK SABR consortium QA sub-group and co-author of the lung chapter of the UK SABR consortium national guidelines. She co-chaired the lung SABR workshop in November 2025 as part of the UKSABR consortium annual conference.